Liam Price just cracked a 60-year-old problem that world-class mathematicians have tried and failed to solve. He’s 23 years old and has no advanced mathematics training. What he does have is a ChatGPT ...
Cardiac implantable electronic devices manage arrhythmias but are limited by mechanical failures, infection risks, and poor long-term biocompatibility. Developing a biological alternative that ...
A meta-analysis of 13 studies showed that patients who underwent sentinel node biopsy had a significantly reduced risk of death from melanoma. In addition, an analysis of nine studies showed that the ...
Tens of thousands of shoppers are reporting widespread problems using Amazon’s website, according to reports from outage tracker Downdetector. As of 3:45 p.m. ET on Thursday, March 5, reports of ...
Banks and fintechs globally are under increasing pressure from regulators to improve the effectiveness of their AML programs, not simply maintain compliance checklists. FinCEN’s modernization ...
Suffering from hair envy? You can now use the same hair products that Manon, Yoonchae, Sophia, Megan, Lara, and Daniela use to get their glossy locks. Manon's go-to products from Matrix are a ...
Sen. Martin Heinrich, D-N.M., listens as Sen. Mike Rounds, R-S.D., speaks during a news conference at the Capitol on May 15, 2024 in Washington, D.C. (Photo by Kent Nishimura/Getty Images) Congress is ...
My friend recently attended a funeral, and midway through the eulogy, he became convinced that it had been written by AI. There was the telltale proliferation of abstract nouns, a surfeit of ...
Nahda Nabiilah is a writer and editor from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. Most of the time, writing gaming guides is a blast for ...
Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...